|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/506 | |||
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Number of the document | 3200775 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15782164.6 |
| Date of filing the European patent application | 2015-10-02 | |
| (97) | Date of publication of the European application | 2017-08-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/053799 |
| Date | 2015-10-02 |
| (87) | Number | WO 2016/054555 |
| Date | 2016-04-07 |
| (30) | Number | Date | Country code |
| 201462059832 P | 2014-10-03 | US |
| (72) |
CAO, Zhu, Alexander, US
RONG, Xianhui, US
PINZON-ORTIZ, Maria, Consuelo, US
LONGMIRE, Tyler, US
LEE, Benjamin, Hyun, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION THERAPIES |
| COMBINATION THERAPIES |